Primary cutaneous B-cell lymphoma: Review and current concepts

Journal of Clinical Oncology

Volumn 18, Issue 10, 2000, Pages 2152-2168

  Pandolfino, Tomi L ^a   Siegel, Richard S ^a   Kuzel, Timothy M ^a   Rosen, Steven T ^a   Guitart, Joan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN LYMPHOMA;

EID: 0034034733     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.10.2152     Document Type: Review

References (123)

1. Burg G, Kerl H, Przybilla B, et al: Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas. J Dermatol Surg Oncol 10:256-262, 1984
2. Isaacson P, Wright DH: Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 53:2515-2524, 1984
3. Slater D: Cutaneous B-cell lymphoproliferative diseases: A centenary celebration classification. J Pathol 172:301-305, 1994
4. Sterry W, Kruger GRF, Steigleder GK: Skin involvement of malignant B-cell lymphomas. J Dermatol Surg Oncol 10:276-277, 1984
5. Willemze R, Kerl H, Sterry W, et al: EORTC classification for cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354-371, 1997
6. Kerl H, Cerroni L: Primary B-cell lymphomas of the skin. Ann Oncol 8:S29-S32, 1997
7. Burg G, Kempf W, Haeffner AC, et al: Cutaneous lymphomas. Curr Probl Dermatol 9:137-204, 1997
8. Caro WA, Helwig EB: Cutaneous lymphoid hyperplasia. Cancer 24:487-502, 1969
9. Garcia CF, Weiss LM, Warnke RA, et al: Cutaneous follicular lymphoma. Am J Surg Pathol 10:454-463, 1986
10. Burg G, Kaudewitz P, Klepzig K, et al: Cutaneous B-cell lymphoma. Dermatol Clin 3:689-704, 1985
11. Wood GS, Weiss LM, Warnke RA, et al: The immunopathology of cutaneous lymphomas: Immunophenotypic and immunogenotypic characteristics. Semin Dermatol 5:334-345, 1986
12. Long JC, Mihm MC, Qazi R: Malignant lymphoma of the skin: A clinicopathologic study of lymphoma other than mycosis fungoides diagnosed by skin biopsy. Cancer 38:1282-1296, 1976
13. Burke JS, Hoppe RT, Cibull ML, et al: Cutaneous malignant lymphoma: A pathologic study of 50 cases with clinical analysis of 37. Cancer 47:300-310, 1981
14. Evans HL, Winkelmann RK, Banks PM: Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: A study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin. Cancer 44:699-717, 1979
15. Berti E, Alessi E, Caputo R, et al: Reticulohistiocytoma of the dorsum. J Am Acad Dermatol 19:259-272, 1988
16. Pimpinelli M, Santucci M, Bosi A, et al: Primary cutaneous follicular centre-cell lymphoma: A lymphoproliferative disease with favourable prognosis. Clin Exper Dermatol 14:12-19, 1989
17. Willemze R, Meijer CJLM, Sentis HJ, et al: Primary cutaneous large cell lymphomas of follicular center cell origin. J Am Acad Dermatol 16:518-526, 1987
18. Rijlaarsdam JU, Meijer CJLM, Willemze R: Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas. Cancer 65:2301-2306, 1990
19. Santucci M, Pimpinelli N, Arganini L: Primary cutaneous B-cell lymphoma: A unique type of low-grade lymphoma. Cancer 67:2311-2326, 1991
20. Rijlaarsdam JU, Toonstra J, Meijer OWM, et al: Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol 14:549-555, 1996
21. Pimpinelli N, Santucci M. Carli P, et al: Primary cutaneous follicular center cell lymphoma: Clinical and histological aspects. Curr Probl Dermatol 19:203-220, 1990
22. Pimpinelli N, Santucci M, Moria M, et al: Primary cutaneous B-cell lymphoma: A clinically homogeneous entity? J Am Acad Dermatol 37:1012-1016, 1997
23. Metze D, Jurecka W. Gebhart W, et al: Immunohistochemical demonstration of immunoglobulin A in human sebaceous and sweat glands. J Invest Dermatol 92:13-17, 1989
24. Okada T, Konishi H, Ito M, et al: Identification of secretory immunoglobulin A in human sweat and sweat glands. J Invest Dermatol 90:648-651, 1988
25. Luger TA, Schwarz T, Krutmann J, et al: Cytokines and the skin. Curr Probl Dermatol 19:35-49, 1990
26. Dommann SN, Dommann-Scherrer CC, Ziegler T, et al: Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas: A comparative study between nodal and cutaneous lymphomas. Am J Dermatopathol 19:391-395, 1997
27. McGregor JM, Yu CC, Lu QL, et al: Posttransplant cutaneous lymphoma. J Am Acad Dermatol 29:549-554, 1993
28. Slater D: Epstein-Barr virus: An aetiological factor in cutaneous lymphoproliferative disorders? J Pathol 165:1-4, 1991
29. Peris K, Niedermeyer H, Cerroni L, et al: Detection of Epstein-Barr virus genome in primary cutaneous T and B cell lymphomas and pseudolymphomas. Arch Dermatol Res 286:364-368, 1994
30. LeBoit PE, McNutt NS, Reed JA, et al: Primary cutaneous immunocytoma: A B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia. Am J Surg Pathol 18:969-978, 1994
31. Burg G, von der Helm D, Kaudewitz P, et al: Antihuman T-cell leukemia/lymphoma virus antibodies in three patients with primary cutaneous B-cell lymphoma. J Dermatol Surg Oncol 14:653-656, 1988
32. Garbe C, Stein H, Dienemann D, et al: Borrelia burgdorferi-associated cutaneous B cell lymphoma: Clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 24:584-590, 1991
33. Cerroni L, Zochling N, Putz B, et al: Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 24:457-461, 1997
34. Kutting B, Bonsmann G, Metze D, et al: Borrelia burgdorferi-associated primary cutaneous B-cell lymphoma: Complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol 36:311-314, 1997
35. Dillon WI, Saed GM, Fivenson DP: Borrelia burgdorferi DNA is undetectable by polymerase chain reaction is skin lesions of morphea, scleroderma, or lichen sclerosis et atrophicus of patients from North America. J Am Acad Dermatol 33:617-620, 1995
36. Weiss LM, Warnke RA, Sklar J, et al: Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 317:1185-1189, 1987
37. Kluin PM, van Krieken JHJM: The molecular biology of B-cell lymphoma: Clinicopathologic implications. Ann Hematol 62:95-102, 1991
38. Yunis JJ, Oken MM, Kaplan ME, et al: Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphomas. N Engl J Med 307:1231-1236, 1982
39. Delia D, Borrello MG, Berti E, et al: Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas. Cancer Res 49:4901-4905, 1989
40. Cerroni L, Volkenandt M, Rieger E, et al: Bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 102:231-235, 1994
41. Neri A, Fracchiolla NS, Roscetti E, et al: Molecular analysis of cutaneous B- and T-cell lymphomas. Blood 86:3160-3172, 1995
42. Triscott JA, Ritter JH, Swanson PE, et al: Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias. J Cutan Pathol 22:2-10, 1995
43. Dubus P, Vergier B, Beylow-Barry M, et al: Contribution of histopathologic and molecular analyses to the diagnosis of cutaneous B-cell infiltrates. Mod Pathol 9:1147-1155, 1996
44. Kerl H, Kresbach H: Germinal center cell-derived lymphomas of the skin. J Dermatol Surg Oncol 10:291-295, 1984
45. Slater DN: MALT and SALT: The clue to cutaneous B-cell lymphoproliferative disease. Br J Dermatol 131:557-561, 1994
46. Slater DN: Review of investigative diagnostic techniques for cutaneous lymphoma. Semin Dermatol 13:166-171, 1994
47. th Ann Meet Soc Invest Dermatol J Invest Dermatol 112:630, 1999 (abstr 648)
48. Weinstock MA, Horm JW: Mycosis fungoides in the United States: Increasing incidence and descriptive epidemiology. JAMA 260:42-46, 1988
49. Kerl H, Burg G: Histomorphology and cytomorphology of cutaneous B-cell lymphomas. J Dermatol Surg Oncol 10:266-270, 1984
50. Willemze R, Meijer CJLM: Analysis of non-neoplastic cells in cutaneous B-cell lymphomas. J Dermatol Surg Oncol 10:315-318, 1984
51. Berti E, Gianotti R, Alessi E, et al: Primary cutaneous follicular center cell lymphoma: Immunophenotypical and immunogenotypical aspects. Curr Probl Dermatol 19:196-202, 1990
52. Smoller BR: The role of immunohistochemistry in the diagnosis of cutaneous lymphoma. Adv Dermatol 207-233, 1988
53. Medeiros LJ, Picker LJ, Abel EA, et al: Cutaneous lymphoid hyperplasia: Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma. J Am Acad Dermatol 21:929-942, 1989
54. Sanueza OP, Yadav S, White CR Jr, et al: Evolution of B-cell lymphoma from pseudolymphoma: A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis. Am J Dermatopathol 14:408-413, 1992
55. Burg G, Kerl H, Kaudewitz P, et al: Immunoenzymatic typing of lymphoplasmacytoid skin infiltrates. J Dermatol Surg Oncol 10:284-290, 1984
56. Hammer E, Sangueza O, Suwanjindar P, et al: Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias. J Am Acad Dermatol 28:426-433, 1993
57. Wood GS, Ngan BY, Tung R, et al: Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia. Am J Pathol 135:13-19, 1989
58. Ritter JH, Adesokan PN, Fitzgibbon JF, et al: Paraffin section immunohistochemistry as an adjunct to morphologic analysis in the diagnosis of cutaneous lymphoid infiltrates. J Cutan Pathol 21:481-493, 1994
59. Weiss LM, Wood GS, Nickoloff BJ, et al: Gene rearrangement studies in lymphoproliferativce disorders of skin. Adv Dermatol 3:141-160, 1988
60. Wood GS: Recent advances in the molecular biology of cutaneous lymphomas and related disorders. Semin Dermatol 10:172-177, 1991
61. Zelickson BD, Peters MS, Pittelkow MR: Gene rearrangement analysis in lymphoid neoplasia. Clin Dermatol 9:119-128, 1991
62. Xerri L, Horschowski N, Boudaouara T, et al: Cutaneous lymphomas of phenotypically undetermined lineage: Contribution of genotypic analysis. J Am Acad Dermatol 25:33-40, 1991
63. Chen YT, Godwin TA, Mouradian JA: Immunohistochemistry and gene rearrangement studies in the diagnosis of malignant lymphomas: A comparison of 152 cases. Hum Pathol 22:1249-1257, 1991
64. Liang G, Pardo RJ, Woight W, et al: Studies of immunoglobulin and T-cell receptor gene rearrangement in cutaneous B and T-cell lymphomas. J Am Acad Dermatol 21:457-460, 1989
65. Peris K, Caracciolo E, Weirich G, et al: Primary centroblastic/ centrocytic lymphoma of the skin: Detection of B-cell monoclonality by polymerase chain reaction. Am J Dermatopathol 17:506-510, 1995
66. Cleary ML, Chao J, Warnke R, et al: Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci USA 81:593-597, 1984
67. Ritter JH, Wick MR, Adesokan PN, et al: Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol 108:60-68, 1997
68. Gellrich S, Golembowski S, Audring H, et al: Molecular analysis of the immunoglobulin VH gene rearrangement in a primary cutaneous immunoblastic B-cell lymphoma by micromanipulation and single-cell PCR. J Inv Dermatol 109:541-545, 1997
69. Cerroni L, Minkus G, Putz B, et al: Laser beam microdissection in the diagnosis of cutaneous B-cell lymphoma. Br J Dermatol 136:743-746, 1997
70. th Ann Meet Soc Invest Dermatol J Invest Dermatol 112:580, 1999 (abstr 344)
71. Rijlaarsdam JU, Bruynzeel DP, Vos W, et al: Immunohistochemical studies of lymphadenosis benigna cutis occurring in a tattoo. Am J Dermatolpathol 10:518-523, 1988
72. Blumental G, Okun MR, Ponitch JA: Pseudolymphomatous reaction to tattoos. J Am Acad Dermatol 6:485-488, 1982
73. Adams JD: Localized cutaneous pseudolymphoma associated with phenytoin therapy: A case report. Australas J Dermatol 22:28-29, 1981
74. Goerdt S, Spieker T, Wolffer LU, et al: Multiple cutaneous B-cell pseudolymphomas after allergen injections. J Am Acad Dermatol 34:1072-1074, 1996
75. Rijlaarsdam JU, Meijer CJLM, Willemze R: Lymphadenosis benigna cutis versus primary cutaneous B-cell lymphomas of follicular center cell origin. Curr Probl Dermatol 19:189-195, 1990
76. Burg G, Kerl H, Schmoeckel C: Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol 10:271-275, 1984
77. Kerl H, Smolle J: Classification of cutaneous pseudolymphomas. Curr Probl Dermatol 19:167-175, 1990
78. Wechsler J, Bagot M, Henni T, et al: Cutaneous pseudolymphomas: Immunophenotypical and immunogenotypical studies. Curr Probl Dermatol 19:183-188, 1990
79. Burg G, Schmid MH, Kung E, et al: Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas. Dermatol Clin 12:399-407, 1994
80. Miracco C, Spina D, Santopietro R, et al: Apoptotic index: Discriminant feature for the differentiation of cutaneous diffuse malignant follicular center cell lymphomas from lymphoid hyperplasia. J Inv Dermatol 100:699-704, 1993
81. Harris NL, Jaffe ES, Stein, H, et al: The revised European-American classification of lymphoid neoplasms (REAL): A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
82. Chimenti S, Cerroni L, Zenahlik P, et al: The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation. J Cut Pathol 23:319-322, 1996
83. Rijlaarsdam JU, Van der Putte SCJ, Berti E, et al: Cutaneous immunocytomas: A clinicopathologic study of 26 cases. Histopathol 23:117-125, 1993
84. Cerroni L, Signoretti S, Hofler G, et al: Primary cutaneous marginal zone B-cell lymphoma: A recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 21:1307-1315, 1997
85. Sangueza OP, Burket JM, Sacks Y: Primary cutaneous immunocytoma: Report of an unusual case with secondary spreading to the gastrointestinal tract. J Cutan Pathol 24:43-46, 1997
86. Bailey EM, Ferry JA, Harris NL, et al: Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue. Am J Surg Pathol 20:1011-1023, 1996
87. Duncan LM, LeBoit PE: Are primary cutaneous immunocytoma and marginal zone lymphoma the same disease? Am J Surg Pathol 21:1368-1372, 1997
88. Dierlamm J, Pittaluga S, Wlodarska I, et al: Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 87:299-307, 1996
89. Vermeer MH, Geelen FAMJ. van Haselen CW, et al: Primary cutaneous large B-cell lymphomas of the legs: A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Arch Dermatol 132:1304-1308, 1996
90. Kurtin PJ, DiCaudo DJ, Habermann TM, et al: Primary cutaneous large cell lymphomas: Morphologic, immunophenotypic, and clinical features of 20 cases. Am J Surg Pathol 18:1183-1191, 1994
91. Joly P, Thomine E, Lauret P: Cutaneous lymphomas other than Mycosis fungoides. Semin Dermatol 13:172-179, 1994
92. Torne R, Su WPD, Winkelmann RK, et al: Clinicopathologic study of cutaneous plasmacytoma. Int J Dermatol 29:562-566, 1990
93. Patterson JW, Parsons JM, White RM, et al: Cutaneous involvement of multiple myeloma and extramedullary plasmacytoma. J Am Acad Dermatol 19:879-890, 1988
94. Alberts DS, Lynch P: Cutaneous plasmacytomas in myeloma. Arch Dermatol 114:1784-1787, 1978
95. Jorizzo JL, Gammon WR, Briggaman RA: Cutaneous plasmacytomas: A review and presentation of an unusual case. J Am Acad Dermatol 1:59-66, 1979
96. LaPerriere HJ, Wolf JE, Gellin GA: Primary cutaneous plasmacytoma. Arch Dermatol 107:99-100, 1973
97. Canlas MS, Dillion ML, Loughrin JJ: Primary cutaneous plasmacytoma. Arch Dermatol 115:722-724, 1979
98. Green T, Grant J, Pye R, et al: Multiple primary cutaneous plasmacytomas. Arch Dermatol 128:962-965, 1992
99. Wong KF, Chan JKC, Li LPK, et al: Primary cutaneous plasmacytoma-report of two cases and review of the literature. Am J Dermatopathol 16:392-397, 1994
100. Miyamoto T, Kobayashi T, Hagari Y, et al: The value of genotypic analysis in the assessment of cutaneous plasmacytomas. Br J Dermatol 137:418-421, 1997
101. Hedinger E: Zur Frage des plasmacytomas. Frankfurt Z Pathol 7:343-350, 1911
102. Pfleger L, Tappeiner J: Zur Kenntnis der systemisierten endotheliomatose der cutanen blutgefasse (reticulo-endomeliose?). Hautarzt 10:359-363, 1959
103. Perniciaro C, Winkelmann RK, Daoud MS, et al: Malignant angioendotheliomatosis is an angiotropic intravascular lymphoma: Immunohistochemical, ultrastructural, and molecular genetics studies. Am J Dermatopathol 17:242-248, 1995
104. Wick MR, Mills SE, Scheithauer BW, et al: Reassessment of malignant "angioendotheliomatosis:" Evidence in favor of its reclassification as "intravascular lymphomatosis." Am J Surg Pathol 10:112-123, 1986
105. Berger TG, Dawson NA: Angioendotheliomatosis. J Am Acad Dermatol 18:407-412, 1988
106. Willemze R, Kruyswijk MRJ, De Bruin CD, et al: Angiotropic (intravascular) large cell lymphoma of the skin previously classified as malignant angioendotheliomatosus. Br J Dermatol 116:393, 1987
107. Petroff N, Koger OW, Fleming MG, et al: Malignant angioendotheliomatosis: An angiotropic lymphoma. J Am Acad Dermatol 21:727-733, 1989
108. William REA, Seywright MM, Lever R, et al: Angiotropic B-cell lymphoma (malignant angioendotheliomatosis): Failure of systemic chemotherapy. Br J Dermatol 123:807-810, 1990
109. Vandenberghe E: Mantle cell lymphoma. Blood Rev 8:79-87, 1994
110. Bertero M, Novelli M, Fierro MT, et al: Mantle zone lymphoma: An immunohistologic study of skin lesions. J Am Acad Dermatol 30:23-30, 1994
111. Weisenburger DD, Kim H, Rappaport H: Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer 49:1429-1438, 1982
112. Arai E, Sakurai M, Nakayama H, et al: Primary cutaneous T-cell-rich B-cell lymphoma. Br J Dermatol 129:196-200, 1993
113. Sander CA, Kaudewitz P, Kutzner H, et al: T-cell-rich B-cell lymphoma presenting in skin: A clinicopathologic analysis of six cases. J Cutan Pathol 23:101-108, 1996
114. Ramsay AD, Smith WJ, Isaacson PG: T-cell-rich B-cell lymphoma. Am J Surg Pathol 2:433-443, 1988
115. Landa NF, Zelickson BD, Kurtin PJ, et al: Primary B-cell lymphoma with histologic features of a T-cell neoplasm. J Am Acad Dermatol 26:288-291, 1992
116. Navarro JT, Ribera JM, Vaquero M, et al: Erythema nodosum as a presenting feature of T-cell rich B-cell lymphoma. Ann Hematol 70:107-108, 1995
117. Lopez-Guillermo A, Montserrat E, Basch F, et al: Applicability of the international index for aggressive lymphomas to patients with low-grade lymphomas. J Clin Oncol 12:1343-1348, 1994
118. Joly P, Vasseur E, Esteve E, et al: Primary cutaneous medium and large cell lymphomas other than mycosis fungoides: An immunohistological and follow-up study of 54 cases. Br J Dermatol 132:506-512, 1995
119. Joly P, Charlotte F, Leibowitch M, et al: Cutaneous lymphoma other than mycosis fungoides: Follow-up study of 52 patients. J Clin Oncol 9:1994-2001, 1991
120. Zenone T, Catimel G, Barbet N, et al: Complete remission of a primary cutaneous B-cell lymphoma treated with intralesional recombinant interferon alpha-2a. Eur J Cancer 30A:246-247, 1994
121. Piccinno R, Caccialanza M, Berti E, et al: Radiotherapy of cutaneous B-cell lymphomas: Our experience in 21 cases. Int J Rad Oncol Biol Phys 27:385-389, 1993
122. Brice P, Cazals D, Mounier N, et al: Primary cutaneous large-cell lymphoma: Analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Leukemia 12:213-219, 1998
123. Maloney DG, Grillo-Lopez AJ, White CA, et al: IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188-2195, 1997